These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3974406)

  • 1. Interaction between warfarin and nonsteroidal anti-inflammatory drugs (NSAIDs) in rats.
    Sancilio LF; Taylor MA; Mathur PP; Crowe JT
    Life Sci; 1985 Mar; 36(11):1041-50. PubMed ID: 3974406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of feprazone and phenylbutazone interaction with warfarin in man.
    Chierichetti S; Bianchi G; Cerri B
    Curr Ther Res Clin Exp; 1975 Oct; 18(4):568-72. PubMed ID: 810317
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylbutazone-warfarin interaction in the dog.
    Bachmann KA; Burkman AM
    J Pharm Pharmacol; 1975 Nov; 27(11):832-6. PubMed ID: 1491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereoselective interaction of phenylbutazone with [12C/13C]warfarin pseudoracemates in man.
    O'Reilly RA; Trager WF; Motley CH; Howald W
    J Clin Invest; 1980 Mar; 65(3):746-53. PubMed ID: 7354137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism for potentiation of warfarin by phenylbutazone. Inhibition of vitamin K-dependent carboxylation and prothrombin synthesis by phenylbutazone in preparations from rat liver.
    Kelly LJ; Bell RG
    Biochem Pharmacol; 1981 Sep; 30(17):2443-9. PubMed ID: 21043243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Warfarin. Stereochemical aspects of its metabolism and the interaction with phenylbutazone.
    Lewis RJ; Trager WF; Chan KK; Breckenridge A; Orme M; Roland M; Schary W
    J Clin Invest; 1974 Jun; 53(6):1607-17. PubMed ID: 4830225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative pharmacokinetics of coumarin anticoagulants XLV: Pharmacokinetic and pharmacodynamic studies of acute interaction between warfarin and phenylbutazone in rats.
    Yacobi A; Lai CM; Levy G
    J Pharm Sci; 1980 Jan; 69(1):14-20. PubMed ID: 7354432
    [No Abstract]   [Full Text] [Related]  

  • 9. Warfarin-phenylbutazone interaction in man: a long term multiple dose study.
    Schary WL; Lewis RJ; Rowland M
    Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):663-72. PubMed ID: 1153844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in the effects of warfarin in dogs by halofenate: an influence upon the kinetics of prothrombin.
    Weintraub M; Griner PF
    Thromb Diath Haemorrh; 1975 Nov; 34(2):445-54. PubMed ID: 1198407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence of indometacin farnesil on blood coagulation. Comparison with indomethacin in normal rats and warfarin induced hypoprothrombinemic rats].
    Hara K; Akiyama Y; Kato Y; Orikasa E; Takahira H; Tajima T
    Nihon Yakurigaku Zasshi; 1988 Dec; 92(6):365-73. PubMed ID: 3250914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic analysis of potentiating effect of phenylbutazone on anticoagulant action of warfarin in man.
    O'Reilly RA; Levy G
    J Pharm Sci; 1970 Sep; 59(9):1258-61. PubMed ID: 5469787
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antiedema effects of basic nonsteroidal anti-inflammatory drugs that are not inhibitors of prostaglandin biosynthesis].
    Higuchi S; Otomo S; Aihara H
    Nihon Yakurigaku Zasshi; 1985 May; 85(5):343-6. PubMed ID: 4029806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The binding of sodium warfarin to plasma albumin and its displacement by phenylbutazone.
    O'Reilly RA
    Ann N Y Acad Sci; 1973 Nov; 226():293-308. PubMed ID: 4520398
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in rats on the mechanism by which 6-mercaptopurine inhibits the anticoagulant effect of warfarin.
    Martini A; Jähnchen E
    J Pharmacol Exp Ther; 1977 Jun; 201(3):547-53. PubMed ID: 864594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of human analgesic dosages of nonsteroidal anti-inflammatory drugs (NSAIDs) from analgesic ED50 values in mice.
    Pong SF; Demuth SM; Kinney CM; Deegan P
    Arch Int Pharmacodyn Ther; 1985 Feb; 273(2):212-20. PubMed ID: 3873924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of anticoagulant effect of warfarin by phenylbutazone.
    Aggeler PM; O'Reilly RA; Leong L; Kowitz PE
    N Engl J Med; 1967 Mar; 276(9):496-501. PubMed ID: 6018280
    [No Abstract]   [Full Text] [Related]  

  • 18. Lack of pharmacodynamic interaction between pentoxifylline and warfarin in the rat.
    Luke DR; O'Donnell MP; Keane WF; Matzke GR
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):65-72. PubMed ID: 3797806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic drug interactions with nonsteroidal anti-inflammatory drugs.
    Brouwers JR; de Smet PA
    Clin Pharmacokinet; 1994 Dec; 27(6):462-85. PubMed ID: 7882636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benorylate interaction with indomethacin and phenylbutazone.
    Khalili-Varasteh H; Rosner I; Legros J
    Arch Int Pharmacodyn Ther; 1976 Jan; 219(1):149-59. PubMed ID: 5064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.